Journal Home
Search for

Volume 14, Issue 5, Pages 453-455 (December 2003)


View previous. 11 of 22 View next.

Sources of injecting equipment for drug users in Moscow, Russia

Maxim N TrubnikovaCorresponding Author Informationemail address, Lev N Khodakevichb, Dmitry A Barkovcemail address, Dmitry V Blagovodemail address

Received 1 December 2002; received in revised form 15 March 2003; accepted 24 June 2003.

Abstract 

Syringe exchange programmes (SEPs) were approved in Moscow in 2002 and studies to evaluate access to sterile syringes are now needed. Clients of a non-governmental organisation (NGO) providing outreach to IDUs were interviewed concerning behaviours within the previous 30 days. Of 232 IDUs, 64% were male, mean age was 25 and mean duration of injection drug use was 5.8 years. Twelve percent reported injecting with used syringes and using prefilled syringes; 6% passed syringes to others and 91% shared paraphernalia. Seventy nine per cent admitted that they had never had a sterile syringe every time they needed it. Among women, 45% used pharmacies as their only source of injecting equipment. Out of 10 potential syringe sources, pharmacies were the major source, especially for women. The other two major sources were other drug users and drug dealers. NGOs offering syringe exchange were mentioned by 9%, whereas medical institutions were reported as the least popular source. Almost all (99%) reported that syringes are not expensive and their procurement is not difficult, but 83% mentioned that buying syringes at pharmacies often involves a risk of being examined by law enforcement staff. These results indicate that significant barriers for procurement and use of sterile syringes exist in Moscow.

a Technical Cooperation, Canadian Embassy, Starokonyushenny per., 23 119002 Moscow, Russia

b ul. Novikova, 12 – 2, apt. 23, 123098 Moscow, Russia

c Moscow Region Narcological Dispensary, ul. Bolshaya Pochtovaya, 40 107082 Moscow, Russia

d “Vozvraschenije k zhizni”, ul. Suvorovskaya 2/1, 107023 Moscow, Russia

Corresponding Author InformationCorresponding author. Tel.: +7-095-105-60-97.

PII: S0955-3959(03)00145-2

doi:10.1016/S0955-3959(03)00145-2


View previous. 11 of 22 View next.